Home/Molecure/Michał Walczak, PhD
MW

Michał Walczak, PhD

Chief Scientific Officer

Molecure

Roles

Chief Scientific OfficeratMolecure
Chief Executive Officer, Chief Scientific OfficeratCaptor Therapeutics

Molecure Pipeline

DrugIndicationPhase
OATD-01Idiopathic Pulmonary Fibrosis (IPF)Phase II
OATD-02Oncology (Solid Tumors)Phase I
RNA Platform ProgramsUndisclosed Oncology TargetsDiscovery
PPI Platform ProgramsUndisclosed Oncology & Immunology TargetsDiscovery